Skip to main content
logo
Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
25.85
-0.18 (-0.69%)
At close: Jun 18, 2026, 4:00 PM EDT
25.92
+0.07 (0.27%)
After-hours: Jun 18, 2026, 7:58 PM EDT

Parabilis Medicines Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Net Income
-145.89-117.91
Depreciation & Amortization
2.52.11
Stock-Based Compensation
3.324.31
Other Adjustments
7.246.97
Changes in Accounts Payable
13.599.28
Changes in Other Operating Activities
-4.47-8.37
Operating Cash Flow
-123.71-103.61
Capital Expenditures
-0.31-0.88
Purchases of Investments
-16.66-90.86
Proceeds from Sale of Investments
56.73121.98
Investing Cash Flow
39.7630.24
Long-Term Debt Repaid
-3.08-
Net Long-Term Debt Issued (Repaid)
-3.08-
Issuance of Common Stock
0.031.07
Net Common Stock Issued (Repurchased)
0.031.07
Issuance of Preferred Stock
67.4977.51
Net Preferred Stock Issued (Repurchased)
67.4977.51
Other Financing Activities
-0.06-0.51
Financing Cash Flow
64.3878.07
Net Cash Flow
-19.574.7
SEC Filings: 10-K · 10-Q